(Huffington Post ) The Food and Drug Administration has fast-tracked human tests of what may be the first cure for methamphetamine addiction. The drug also may be the first non-opiate drug treatment for heroin and opiate addiction.

In a recent trial, UCLA researchers administered the drug Ibudilast, or MN-166, to 11 non-treatment-seeking meth addicts. The trial, the first of three phases of Ibudilast human testing required for FDA approval, was meant to test the safety of the drug taken in combination with meth. Researchers said the treatment appears to have passed the safety test and eased the addiction.

“Very preliminary results would indicate that Ibudilast may dampen craving and improve cognitive functioning,” said Dr. Aimee Swanson, co-investigator on the trial and research director at the UCLA Center for Behavioral and Addiction Medicine.

  • Text smaller
  • Text bigger
Note: Read our discussion guidelines before commenting.